Unknown

Dataset Information

0

A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma.


ABSTRACT:

SUBMITTER: Rosenthal A 

PROVIDER: S-EPMC4820359 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma.

Rosenthal Allison A   Kumar Shaji S   Hofmeister Craig C   Laubach Jacob J   Vij Ravi R   Dueck Amylou A   Gano Katherine K   Stewart A Keith AK  

British journal of haematology 20150925 2


Similar Datasets

| S-EPMC6982547 | biostudies-literature
| S-EPMC4045308 | biostudies-literature
| S-EPMC4110881 | biostudies-literature
| S-EPMC2892955 | biostudies-literature
| S-EPMC4468408 | biostudies-literature
| S-EPMC4229392 | biostudies-literature
| S-EPMC7731903 | biostudies-literature
| S-EPMC3867644 | biostudies-literature
| S-EPMC3297687 | biostudies-literature
| S-EPMC4872349 | biostudies-literature